# Bergamot Cholesterol Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/bergamot-cholesterol-randomized-trial-evidence-review
Category: evidence-review
Summary: Bergamot Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are s
Last reviewed: 2026-07-05
Reviewed by: Migaku Evidence Review
# Bergamot Cholesterol Randomized Trial: What the Evidence Says

## Quick Answer

Bergamot Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials | systematic review | 1 | 2026-01-22 | 10.1111/obr.70094 |
| Unveiling the Power of Bergamot: Beyond Lipid-Lowering Effects | narrative review | 3 | 2025-05-30 | 10.3390/nu17111871 |

## What The Sources Report

- Obesity is a multifactorial disease defined as abnormal or excessive fat accumulation that presents a risk to health because it is a major risk factor for several noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and several types of cancer. [Pujia Carmelo (2026); evidence level 1]
- Furthermore, obesity and its associated health problems have a significant economic impact on the global healthcare system. [Pujia Carmelo (2026); evidence level 1]
- Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, primarily driven by a combination of non-modifiable (gender and family history) and modifiable (e.g., dyslipidemia, hypertension, smoking, diabetes, and obesity) risk factors. [Carpenito Myriam (2025); evidence level 3]
- Among modifiable risk factors, low-density lipoprotein cholesterol (LDL-C) is recognized as the most significant contributor to atherosclerosis. [Carpenito Myriam (2025); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For bergamot cholesterol randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Pujia Carmelo (2026). Effect of
Citrus bergamia
Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. DOI: 10.1111/obr.70094. PMCID: PMC13243342. PMID: 41572527. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13243342/
- Carpenito Myriam (2025). Unveiling the Power of Bergamot: Beyond Lipid-Lowering Effects. DOI: 10.3390/nu17111871. PMCID: PMC12158049. PMID: 40507140. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12158049/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.